A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases - Wikidata - awgldk - TriplyDB

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

http://www.wikidata.org/entity/Q27649303

about

Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B Selective inhibition of BET bromodomains Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G ROR nuclear receptors: structures, related diseases, and drug discovery Bivalent inhibitors of protein kinases Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation Structure of dystrophia myotonica protein kinase Structure and functional characterization of the atypical human kinase haspin Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors Affinity-Based Probes Based on Type II Kinase Inhibitors A Strategy for Modulation of Enzymes in the Ubiquitin System The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors A new class of small molecule inhibitor of BMP signaling Pan-Pathway Based Interaction Profiling of FDA-Approved Nucleoside and Nucleobase Analogs with Enzymes of the Human Nucleotide Metabolism Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies Comprehensive characterization of the Published Kinase Inhibitor Set Protein kinase C mechanisms that contribute to cardiac remodelling Targeting Pim kinases for cancer treatment: opportunities and challenges The PIM kinases in hematological cancers Pim kinase inhibitors: a survey of the patent literature Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases A computational approach to finding novel targets for existing drugs Proteins with complex architecture as potential targets for drug design: a case study of Mycobacterium tuberculosis Applying ligands profiling using multiple extended electron distribution based field templates and feature trees similarity searching in the discovery of new generation of urea-based antineoplastic kinase inhibitors A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination Targeting cancer with small molecule kinase inhibitors Large-scale prediction of drug-target relationships Insights into protein kinase regulation and inhibition by large scale structural comparison IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.Kinome-wide activity modeling from diverse public high-quality data sets

P2860

Q21142745-C4694F30-7836-451D-8C0F-026AEC43F56B Q24297748-61F389BB-0F29-4DFB-AF7B-BEE0FB11E96A Q24300982-09715927-3E98-48F1-9F9C-26E193EEF7CC Q24301009-E8498AB4-9D0D-4F74-BC2D-42F2DE599416 Q24321199-268303A4-F089-4563-B436-E99B1D7350E5 Q24336079-903E13FA-F864-4E4A-8D8D-A819E67DE79D Q24337123-90D7BAA5-6973-4029-A26F-BF052D3C5C46 Q24603099-EEB9930C-D7A6-4336-8E20-9C2809D2BA0F Q24615552-3C6B675D-8347-45EE-B4E3-6CEB2A7A0ACF Q26861208-DA5EC0B9-CC71-48E3-97E5-D6C40C9E550E Q26999008-31B070F7-25B2-459B-B23B-0FDD2BBC2B77 Q27333727-05B1D2E2-8CD5-444E-B337-C8742234FFAE Q27654063-078E7B46-E0AC-49DD-8E01-8D0EE8E34244 Q27654285-A6832540-6C34-489D-BF03-4A1E8D3EFCB6 Q27658205-48625EC6-6599-4F11-B70B-CC3E51BEEE11 Q27666758-4C50CE22-BE3E-4C9D-8791-C33146E25ED6 Q27667351-AB562A97-7618-42CC-8F71-8995ADAF9D1D Q27674665-2EDF100A-6E33-4C97-89C7-75D8BEBEB4D0 Q27675727-29BF6211-5AB4-46DE-916A-9BAC1C41E665 Q27676606-55803E19-F7CA-4E6D-8789-89BA95F092EB Q27677345-2C53C660-424D-4B11-B362-55B89DAD64B7 Q27678000-38BDEFE4-28C0-4CE0-92AF-E5AADE844AD3 Q27679474-9DF6F7B8-26B3-4D5A-8EA1-678C98106DCE Q27681380-C613324B-5EFC-4CA1-9188-551D85D62790 Q27702518-21B19AA4-E8F9-4D69-A06B-DA277126F023 Q28075729-300F59B5-E034-4580-B633-C43E54719594 Q28255361-F9521389-0FF2-4C1E-BD3E-75518FCC7F1C Q28258028-665B26F8-07ED-4C29-BD27-4C39DA4A5ECA Q28271318-8110227B-E240-4508-BCBA-8A953462D9AA Q28289498-34DC6D2A-C43A-458F-984B-7F89249749FF Q28476770-8A0472F5-766A-4180-9EDF-C2F557537091 Q28479221-BBF05010-BDA9-4C0A-8C61-0EF1AD3D2D4A Q28485281-BA5141BD-7800-4ADA-A2B5-B3CC420A4220 Q28539430-5A03417B-A650-4B06-A6D5-6694C9BF8788 Q28539535-8E94340A-AA50-49DD-B79D-3CD5307DA60C Q29547395-AFAAE745-BE74-4D35-B41C-EBA91482C46E Q30002408-914CB38B-FBDB-4FD7-A430-5A0E52770254 Q30381908-0A897FAF-95BA-41D4-9A10-D6A3F720D72D Q30500880-5A603F79-958C-4BBC-8BF4-3C5ABC0FBAF6 Q30582708-4DEF5E75-7E1F-483F-8BBF-214BC79AEDBD

P2860

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

http://www.wikidata.org/entity/Q27649303

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@ast

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@en

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@nl

type

label

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@ast

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@en

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@nl

prefLabel

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@ast

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@en

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@nl

P1433

Q27649303-C705777A-3498-4E3A-A42C-AD31DD7C8565

P1476

Q27649303-7694129E-F6F1-4B29-9E4A-D324F6863942

P2093

Q27649303-21A2E290-551E-41AB-AC74-E89FAB1F466D

Q27649303-2810DCD8-F92D-4854-A840-ECD87882C559

Q27649303-5A1CF26E-B6A9-476A-AA46-A94E510F8E61

Q27649303-ADC2F85E-EB2B-4A10-BA53-0C6A7E03C7AC

Q27649303-DF4C82AB-D1F9-4FA0-BE43-C48AEBE17E1E

Q27649303-E34250D4-1A26-4054-B5DF-C8377271A665

P2860

Q27649303-0EC15F7C-8114-45D6-93C1-61A83D330746

Q27649303-1B41F05D-49A1-41CB-8482-BB980B6B449E

Q27649303-1FB28FAC-5E80-4216-9302-C4FB19631C22

Q27649303-23D2BC2D-CAF0-40A2-A8E6-A1AC941023FF

Q27649303-379A51F6-E067-44A0-9CD1-AB261C1E2D25

Q27649303-38585BDD-5196-4F6E-8A2B-6CA743C6732C

Q27649303-3D26C810-E23E-42B5-BC03-3188285940C4

Q27649303-3FF5B4F9-737D-4FE9-8126-D2CB8D114880

Q27649303-42C66184-B9E2-402A-BD61-07F3E7AE8F03

Q27649303-452138AD-3211-4EB2-A318-A17505E923C3

P304

Q27649303-24103FAA-C64D-4AF5-A6BF-DDF3A4C91ECB

P31

Q27649303-27AC568D-DBCC-4E22-9391-DCF6126AFCF9

P356

Q27649303-DAD283ED-8824-4DA9-B081-07FDF1CE8CBF

P407

Q27649303-5C58D2C8-D1D1-4872-9679-699C8D23CD33

P433

Q27649303-0CEA9F9C-FCF1-46BC-9E7C-962591BC9519

P478

Q27649303-0C50502D-BBAB-4F4B-A66A-35C5C29961FE

P50

Q27649303-9F5C40D9-A105-4549-897E-E1758A1FD3C5

Q27649303-A97BB800-0C42-4291-B536-6590A28A7D10

Q27649303-FA6F7A93-C987-4306-A6FA-CDFC6BEF558F

P577

Q27649303-07D0BBB2-4F4A-4B58-B361-C4B1629A28D4

P5875

Q27649303-1C1D339E-7B8A-4F0A-A8F5-9EEA7192A9A8

P698

Q27649303-FE79D33A-DC87-4606-B386-2192E157EEB3

P932

Q27649303-04B05739-9778-448F-930D-CFF180BD36F3

P356

PNAS.0708800104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases

@en

P2093

Alex N Bullock

http://www.w3.org/2001/XMLSchema#string

Brian Marsden

http://www.w3.org/2001/XMLSchema#string

Juerg Schwaller

http://www.w3.org/2001/XMLSchema#string

Michael Sundström

http://www.w3.org/2001/XMLSchema#string

Peter Rellos

http://www.w3.org/2001/XMLSchema#string

Vanda Pogacic

http://www.w3.org/2001/XMLSchema#string

P2860

Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

The protein kinase complement of the human genome

The selectivity of protein kinase inhibitors: a further update

Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors

Structure and regulation of the human Nek2 centrosomal kinase

Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

Protein kinase C (PKC) family in cancer progression

Current development of mTOR inhibitors as anticancer agents

P304

20523-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0708800104

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Susanne Müller

P577

2007-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5771936

http://www.w3.org/2001/XMLSchema#string

P698

18077363

http://www.w3.org/2001/XMLSchema#string

P932

2154464

http://www.w3.org/2001/XMLSchema#string